Krystal Biotech buy Chardan Capital
Start price
25.07.25
/
50%
€125.75
Target price
25.07.26
€186.52
Performance (%)
19.92%
Price
29.09.25
€150.80
Summary
This prediction is currently active. The prediction currently has a performance of 19.92%. This prediction currently runs until 25.07.26. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | 2.870% | 2.870% |
| iShares Core DAX® | 0.378% | -1.285% |
| iShares Nasdaq 100 | -0.117% | 3.146% |
| iShares Nikkei 225® | -0.806% | 3.298% |
| iShares S&P 500 | 0.059% | 2.018% |
Comments by Chardan_Capital for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $219.00 price target on the stock.
Ratings data for KRYS provided by MarketBeat
Stopped prediction by Chardan_Capital for Krystal Biotech
Krystal Biotech
Start price
Target price
Perf. (%)
€127.05
22.08.25
22.08.25
€186.08
22.08.26
22.08.26
18.69%
29.09.25
29.09.25
Krystal Biotech
Start price
Target price
Perf. (%)
€118.80
05.08.25
05.08.25
€189.46
05.08.26
05.08.26
26.94%
29.09.25
29.09.25
Krystal Biotech
Start price
Target price
Perf. (%)
€116.70
07.05.25
07.05.25
€193.05
07.05.26
07.05.26
29.22%
29.09.25
29.09.25
Krystal Biotech
Start price
Target price
Perf. (%)
€172.25
20.02.25
20.02.25
€208.60
20.02.26
20.02.26
-12.45%
29.09.25
29.09.25
Krystal Biotech
Start price
Target price
Perf. (%)
€151.90
18.12.24
18.12.24
€202.14
18.12.25
18.12.25
-0.72%
29.09.25
29.09.25
Krystal Biotech
Start price
Target price
Perf. (%)
€165.85
12.12.24
12.12.24
€201.99
12.12.25
12.12.25
-9.07%
29.09.25
29.09.25